Universal Vision Biotechnology Co., Ltd.(TW:3218)
NT$126.001.50 (-0.40%)
TW:3218
Universal Vision Biotechnology Co., Ltd. Revenue
NT$126.00
At close:1.50 (-0.40%)
Universal Vision Biotechnology Co., Ltd. (3218) Revenue
Universal Vision Biotechnology Co., Ltd. Revenue
Universal Vision Biotechnology Co., Ltd. had a revenue of 1.13B in the quarter ending Jun 30, 2026, with 3.37%. This bring the company's revenue in the last twelve months to 4.27B, Increased 2.48%. In the fiscal year ending Dec 31, 2025, Universal Vision Biotechnology Co., Ltd. had annual revenue of 4.20B with -0.57% growth.
- Revenue (ttm)
- 4.27B
- Revenue Growth
- 0.24%
- P/S Ratio
- 2.54
- Revenue/Employee
- TWD 10,484,005
- Employees
- 401
- Market Cap
- TWD 10.68B
Revenue Chart
Universal Vision Biotechnology Co., Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.20B | -24.22M | -0.57% |
| Dec 31, 2024 | 4.23B | 146.05M | 3.58% |
| Dec 31, 2023 | 4.08B | 588.20M | 16.83% |
| Dec 31, 2022 | 3.49B | 862.26M | 32.76% |
| Dec 31, 2021 | 2.63B | 578.66M | 28.18% |
| Dec 31, 2020 | 2.05B | 634.16M | 44.69% |
| Dec 31, 2019 | 1.42B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.